- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x COH: PROTOPORPHYRIN IX CONTAINING CO(Covalent)
COH.4: 18 residues within 4Å:- Chain A: Y.117, A.168, F.169, A.171, Q.172, H.176, F.179, K.180, T.181, H.183, V.264, N.351, Y.354, H.355, H.357, L.360, V.416, Q.423
19 PLIP interactions:19 interactions with chain A,- Hydrophobic interactions: A:F.169, A:A.171, A:Q.172, A:F.179, A:F.179, A:V.264, A:V.264, A:L.360, A:L.360, A:V.416
- Hydrogen bonds: A:T.181, A:N.351, A:Q.423
- Salt bridges: A:H.183, A:H.183, A:H.355
- pi-Stacking: A:H.176, A:H.355
- Metal complexes: A:H.357
COH.16: 14 residues within 4Å:- Chain B: Y.117, A.168, Q.172, H.176, F.179, K.180, T.181, H.183, N.351, Y.354, H.355, H.357, L.360, F.364
14 PLIP interactions:14 interactions with chain B,- Hydrophobic interactions: B:Q.172, B:F.179, B:Y.354, B:L.360, B:F.364
- Hydrogen bonds: B:Y.117, B:T.181, B:N.351
- Water bridges: B:H.176, B:F.179
- Salt bridges: B:H.183, B:H.183
- pi-Stacking: B:H.176
- Metal complexes: B:H.357
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 3 residues within 4Å:- Chain A: Y.23, E.35, N.36
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:E.35
- Hydrogen bonds: A:E.35, A:N.36
NAG.6: 5 residues within 4Å:- Chain A: Q.375, N.379, S.381, I.382, E.385
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.385
- Water bridges: A:N.379
NAG.17: 5 residues within 4Å:- Chain B: Q.375, N.379, S.381, I.382, E.385
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.385
- Water bridges: B:N.379
- 4 x AKR: ACRYLIC ACID(Non-covalent)
AKR.7: 4 residues within 4Å:- Chain A: R.209, K.212, A.240, E.241
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Q.239, A:E.241
- Salt bridges: A:R.209, A:K.212
AKR.8: 3 residues within 4Å:- Chain A: T.181, H.183, V.260
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:H.183
- Hydrogen bonds: A:N.191
AKR.18: 5 residues within 4Å:- Chain B: R.209, K.212, Q.239, A.240, E.241
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:R.209
- Hydrogen bonds: B:E.241
- Salt bridges: B:R.209, B:K.212
AKR.19: 5 residues within 4Å:- Chain B: V.235, K.236, Q.239, E.250, R.253
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:V.235, B:K.236, B:K.236
- Hydrogen bonds: B:K.236, B:E.250
- Water bridges: B:R.253
- Salt bridges: B:R.253
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 9 residues within 4Å:- Chain A: F.178, V.197, N.344, I.346, F.350, F.498, S.499, G.502, L.503
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.344
- Water bridges: A:G.502
EDO.10: 5 residues within 4Å:- Chain A: H.320, Q.534, S.548, F.549, S.550
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:H.320, A:Q.534, A:F.549, A:S.550
EDO.11: 6 residues within 4Å:- Chain A: H.195, G.505, N.506, V.507
- Chain B: W.108, F.111
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:H.195, A:V.507
- Water bridges: A:N.344, A:N.344, A:N.506
EDO.12: 5 residues within 4Å:- Chain A: C.4, H.7, C.15, P.122, Q.430
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:C.4, A:H.7
- Water bridges: A:Q.430
EDO.13: 5 residues within 4Å:- Chain A: Y.354, W.356, G.495, A.496, S.499
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.354, A:Y.354
EDO.14: 5 residues within 4Å:- Chain A: R.89, V.318, Y.324, V.492, A.496
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.89, A:Y.324
EDO.15: 6 residues within 4Å:- Chain A: K.220, Y.223, M.230, N.279, R.280, D.283
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.220, A:Y.223, A:Y.223
EDO.20: 8 residues within 4Å:- Chain B: E.277, R.280, E.308, A.531, S.535, L.536, N.539, N.540
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.280, B:S.535, B:N.539, B:N.540
EDO.21: 8 residues within 4Å:- Chain B: F.178, V.197, I.346, F.350, F.498, S.499, G.502, L.503
No protein-ligand interaction detected (PLIP)EDO.22: 6 residues within 4Å:- Chain A: W.108, F.111
- Chain B: H.195, G.505, N.506, V.507
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:H.195, B:V.507
- Water bridges: B:V.197, B:N.344
EDO.23: 1 residues within 4Å:- Chain B: A.80
No protein-ligand interaction detected (PLIP)EDO.24: 6 residues within 4Å:- Chain B: V.85, R.89, V.318, Y.324, A.496, L.500
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.89
EDO.25: 6 residues within 4Å:- Chain B: L.321, L.353, W.356, G.495, A.496, S.499
No protein-ligand interaction detected (PLIP)EDO.26: 4 residues within 4Å:- Chain B: H.91, I.93, D.94, S.95
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.95
- Water bridges: B:S.95
EDO.27: 8 residues within 4Å:- Chain B: H.58, Q.161, L.321, R.482, A.485, I.486, F.487, V.492
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:L.321, B:R.482, B:R.482, B:I.486, B:F.487
- 1 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lucido, M.J. et al., Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry (2016)
- Release Date
- 2016-03-16
- Peptides
- Prostaglandin G/H synthase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x COH: PROTOPORPHYRIN IX CONTAINING CO(Covalent)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x AKR: ACRYLIC ACID(Non-covalent)
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lucido, M.J. et al., Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry (2016)
- Release Date
- 2016-03-16
- Peptides
- Prostaglandin G/H synthase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B